Melatonin: From biochemistry to therapeutic applications

Polish Journal of Pharmacology

Volumn 51, Issue 1, 1999, Pages 3-23

  Zawilska, Jolanta B ^a,b   Nowak, Jerzy Z ^a  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Circadian rhythm; Circadian rhythm sleep disorders; Melatonin; Pineal gland; Retina; Seasonal reproduction; Serotonin N acetyltransferase

Indexed keywords

MELATONIN; MELATONIN RECEPTOR; NEUROTRANSMITTER; SEROTONIN N ACETYLTRANSFERASE;

AGING; CIRCADIAN RHYTHM; CLINICAL TRIAL; DRUG ABSORPTION; DRUG ELIMINATION; GASTROINTESTINAL TRACT; HARDER GLAND; HORMONE SYNTHESIS; HUMAN; LIGHT; NONHUMAN; ORAL DRUG ADMINISTRATION; PHOTOSENSITIVITY; PINEAL BODY; RETINA; REVIEW; SECOND MESSENGER; SIDE EFFECT; SLEEP DISORDER;

AGING; ANIMALS; ANTIOXIDANTS; CIRCADIAN RHYTHM; HUMANS; LIGHT; MELATONIN; NEUROTRANSMITTER AGENTS; PLANT PHYSIOLOGY; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; SEASONS; SLEEP DISORDERS;

EID: 0033010252     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (222)

1. Abuja P. M., Liebmann P., Hayn M., Schauestein K., Esterbauer H.: Antioxidant role of melatonin in lipid peroxidation of human LDL. FEBS Lett., 1997, 413, 289-293.
2. Acuna-Castroviejo D., Coto-Montes A., Monti M. G., Ortiz G. G., Reiter R. J.: Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci., 1997, 60, 23-29.
3. Arendt J.: Melatonin and the Mammalian Pineal Gland. Chapman and Hall, London, 1995.
4. Arendt J.: Safety of melatonin in long-term use (?). J. Biol. Rhythms, 1997, 12, 673-681.
5. Arendt J., Aldhous M., English J., Marks V., Arendt J. H.: Some effects of jet-lag and their alleviation by melatonin. Ergonomics, 1987, 30, 1379-1393.
6. Arendt J., Aldhous M., Wright J.: Synchronization of a disturbed sleep-wake cycle in a blind man by melatonin treatment. Lancet, 1988, 1, 772-773.
7. Arendt J., Deacon S.: Treatment of circadian rhythm disorders - melatonin. Chronobiol. Int., 1997, 14, 185-204.
8. Arendt J., Deacon S., English J., Hampton S., Morgan L.: Melatonin and adjustment to phase shift. J. Sleep Res., 1995, 4 Suppl., 74-79.
9. Arendt J., Skene D. J., Middleton B., Lockey S. W., Deacon S.: Efficacy of melatonin treatment in jet lag, shift work, and blindness. J. Biol. Rhythms, 1997, 12, 604-617.
10. Armstrong S. M.: Treatment of sleep disorders by melatonin administration. In: Advances in Pineal Research, vol. 6. Eds. Reiter R. J., Foldes A., John Libbey, London, 1991, 199-208.
11. Attenburrow M. E. J., Cowen P. J., Sharpley A. L.: Low dose of melatonin improves sleep in healthy middle-aged subjects. Psychopharmacology, 1996, 126, 179-181.
12. Baler R., Coon S. L., Klein D. C.: Orphan nuclear receptor RZRβ: cyclic AMP regulates expression in the pineal gland. Biochem. Biophys. Res. Commun., 1996, 220, 975-978.
13. Baler R., Klein D. C.: Circadian expression of transcription factor Fra-2 in the rat pineal gland. J. Biol. Chem., 1995, 27, 319-325.
14. Barry T. N., Wilson P. R.: The role and use of melatonin for deer production. In: Advances in Pineal Research, vol. 6, Eds. Reiter R. J., Foldes A., John Libbey, London, 1991, 249-58.
15. Becker-Andre M., Wiesenberg I., Schaeren-Wiemers N., Andre E., Missbach M., Saurat J.-H., Carlberg C.: Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem., 1994, 269, 28531-28534.
16. Benitez-King G., Anton-Tay F.: Calmodulin mediates melatonin cytoskeletal effects. Experientia, 1993, 49, 635-641.
17. 3H-melatonin to calmodulin. Life Sci., 1993, 53, 201-207.
18. Benshoff H. M., Brainard G. C., Rollag M. D., Lynch G. R.: Suppression of pineal melatonin in Peromyscus leucopus by different monochromatic wavelengths of visible and near-ultraviolet light (UV-A). Brain Res., 1987, 420, 397-402.
19. Bernard M., Iuvone P. M., Cassone V. M., Roseboom P. H., Coon S. L., Klein D. C.: Avian melatonin synthesis: photic and circadian regulation of serotonin N-acetyltransferase mRNA in the chicken pineal gland and retina. J. Neurochem., 1997, 68, 213-224.
20. Besancon R., Reboul A., Claustrat B., Jouvet A., Belin M.-F., Fevre-Montange M.: Tryptophan hydroxylase mRNAs analysis by RT-PCR: preliminary report on effect of noradrenaline in the neonatal rat pineal gland. J. Neurosci. Res., 1997, 49, 750-758.
21. Binkley S.: The Pineal: Endocrine and Nonendocrine Function. Prentice Hall, Englewood Cliffs, 1988.
22. Binkley S., Hryshschyshyn M., Reilly K.: N-Acetyltransferase activity responds to environmental lighting in the eye as well as in the pineal gland. Nature, 1979, 281, 479-481.
23. Binkley S. A., Riebman J. B., Reilly K. B.: Circadian rhythm of color change in Anolis carolinensis: reconsideration of regulation, especially the role of melatonin in dark-time pallor. Pineal Res. Rev., 1987, 5, 133-151.
24. Blask D. E.: Melatonin in oncology. In: Melatonin: Biosynthesis, Physiological Effects, and Clinical Applications. Eds. Yu H. S., Reiter R. J., CRC Press, Boca Raton, FL, 1993, 447-475.
25. Boivin D. B., Duffy J. F., Kronauer R. E., Czeisler C. A.: Dose-response relationships for resetting of human circadian clock by light. Nature, 1996, 379, 540-542.
26. Borjigin J., Wang M. M., Snyder S. H.: Diurnal variation in mRNA encoding serotonin N-acetyltransferase in pineal gland. Nature, 1995, 378, 783-785.
27. Brainard G. C., Barker F. M., Hoffman R. J., Stetson M. H., Hanifin J. P., Podolin P. L., Rollag M. D.: Ultraviolet regulation of neuroendocrine and circadian physiology in rodents. Vision Res., 1994, 34, 1521-1533.
28. Brainard G. C., Gaddy J. R., Barker F. M., Hanifin J. P., Rollag M. D.: Mechanisms in the eye that mediate the biological and therapeutic effects of light in humans. In: Light and Biological Rhythms in Man. Ed. Wetterberg L., Pergamon Press, Oxford, 1993, 29-54.
29. Brainard G. C., Richardson B. A., King T. S., Reiter R. J.: The influence of different light spectra on the suppression of pineal melatonin content in the Syrian hamster. Brain Res., 1984, 294, 333-339.
30. Brainard G. C., Rollag M. D., Hanifin J. P.: Photic regulation of melatonin in humans: ocular and neural signal transduction. J. Biol. Rhythms, 1997, 12, 537-546.
31. Brown G. M.: Melatonin in psychiatric and sleep disorders. CNS Drugs, 1995, 3, 209-226.
32. Cagnacci A., Arangino S., Angiolucci M., Longu G., Melis G. B.: Potentially beneficial cardiovascular effects of melatonin administration in women. J. Pineal Res., 1997, 22, 16-19.
33. Cagnacci A., Kräuchi K., Wirz-Justice A., Volpe A.: Homeostatic versus circadian effects of melatonin on core body temperature in humans. J. Biol. Rhythms, 1997, 12, 509-517.
34. Cahill G. M.: Circadian regulation of melatonin production in cultured zebrafish pineal and retina. Brain Res., 1996, 708, 177-181.
35. Cahill G. M., Besharse J. C.: Retinal melatonin is metabolized within the eye of Xenopus laevis. Proc. Nat. Acad. Sci. USA, 1989, 80, 1098-1102.
36. 2 dopamine receptors. J. Neurosci., 1991, 11, 2959-2971.
37. Cahill G. M., Besharse J. C.: Circadian clock functions localized in Xenopus retinal photoreceptors. Neuron, 1993, 10, 573-577.
38. Cahill G. M., Besharse J. C.: Circadian rhythmicity in vertebrate retina: regulation by a photoreceptor oscillator. Prog. Retin. Eye Res., 1995, 14, 267-291.
39. Cajochen C., Kraüchi K., Wirz-Justice A.: The acute soporific action of daytime melatonin administration: effects on the EEG during wakefulness and subjective alertness. J. Biol. Rhythms, 1997, 12, 636-643.
40. Cameiro R. C. G., Reiter R. J.: Melatonin protects against lipid peroxidation induced by δ-aminolevulinic acid in rat cerebellum, cortex and hippocampus. Neuroscience, 1998, 82, 293-299.
41. Cassone V. M:. Melatonin and suprachiasmatic nucleus function. In: Suprachiasmatic Nucleus, The Mind's Clock . Eds. Klein D. C., Moore R. Y., Reppert S. M., Oxford University Press, New York, 1991, 309-323.
42. Cassone V. M., Brooks D. S.: Sites of melatonin action in the brain of the house sparrow, Passer domesticus. J. Exp. Zool., 1991, 260, 302-309.
43. Cavallo A.: The pineal gland in human beings: relevance to pediatrics. J. Pediat., 1993, 123, 843-851.
44. Cazevieille C., Osborne N. N.: Retinal neurons containing kainate receptors are influenced by exogenous kainate and ischaemia while neurons lacking these receptors are not - melatonin counteracts the effect of ischaemia and kainate. Brain Res., 1997, 755, 91-100.
45. Cho S., Joh T. H., Baik H. H., Dibinis C., Volpe B. T.: Melatonin administration protects CA1 hippocampal neurons from transient forebrain ischemia in rats. Brain Res., 1997, 755, 335-338.
46. Claustrat B., Brun J., David M., Sassolas G., Chazot G.: Melatonin and jet lag: confirmatory results using a simplified protocol. Biol. Psychiat., 1992, 32, 705-711.
47. Coon S.L., Mazuruk K., Bernard M., Roseboom P. H., Klein D. C., Rodriguez I. R.: The human serotonin N-acetyltransferase (EC 2.3.1.87) gene (AANAT): structure, chromosomal localization and tissue expression. Genomics, 1996, 34, 76-84.
48. Coon S. L., Roseboom P. H., Baler R., Weller J. L., Namboodiri M. A. A., Koonin E. V., Klein D. C.: Pineal serotonin N-acetyltransferase (EC 2.3.1.87): expression cloning and molecular analysis. Science, 1995, 270, 1681-1683.
49. Copinga S., Tepper P. G., Grol C. J., Horn A. S., Dubocovich M. L.: 2-Amido-8-methoxytetralins: a series of nonindolic melatonin-like agents. J. Med. Chem., 1993, 36, 2891-2898.
50. Czeisler C. A.: The effect of light on the human circadian pacemaker. In: Circadian Clocks and Their Adjustment. Ed. Waterhouse J. M., Willey, Chichester, 1995, 254-302.
51. Dagan Y., Yovel I., Hallis D., Eisentein M., Raichik I.: Evaluating the role of melatonin in the long-term treatment of delayed sleep phase syndrome (DSPS). Chronobiol. Int., 1998, 15, 181-190.
52. Dahlitz M., Alvarez B., Vignau J., English J., Arendt J., Parkes J. D.: Delayed sleep phase syndrome response to melatonin. Lancet, 1991, 337, P1121-1124.
53. Davies B., Hannah L. T., Randall C. F., Bromage N., Williams L. M.: Central melatonin binding sites in rainbow trout (Onchorhynchus mykiss). Gen. Comp. Endocrinol., 1994, 96, 19-26.
54. Davis F. C.: Melatonin: role in development. J. Biol. Rhythms, 1997, 12, 498-508.
55. Dawson D., Encel N.: Melatonin and sleep in humans. J. Pineal Res., 1993, 15, 1-12.
56. Deguchi T.: Physiology and molecular biology of arylamine N-acetyltransferases. Biomed. Res., 1992, 13, 231-242.
57. Dijk D.-J., Cajochen C.: Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG. J. Biol. Rhythms, 1997, 12, 627-635.
58. Dijk D.-J., Czeisler C.: Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves and spindle activity in humans. J. Neurosci., 1995, 15, 3526-3538.
59. Dijk D.-J., Roth C., Landolt H. P., Werth E., Aeppli M., Achermann P., Borbély A. A.: Melatonin effects on daytime sleep in men: suppression of EEG low frequency activity and enhancement of spindle frequency activity. Neurosci. Lett., 1995, 201, 13-16.
60. Dollins A. B., Zhdanova I. V., Wurtman J. R., Lynch H. J., Deng M. H.: Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc. Nat. Acad. Sci. USA, 1994, 91, 1824-1828.
61. Drijfhout W. J., van der Linde A. G., Kooi S. E., Grol C. J, Westerink B. H. C.: Norepinephrine release in the rat pineal gland: the input from the biological clock measured by in vivo microdialysis. J. Neurochem., 1996, 66, 748-755.
62. Dubocovich M. L.: Pharmacology and function of melatonin receptors. FASEB J., 1988, 2, 2765-2773.
63. Dubocovich M. L., Cardinali D. P., Guardiola-Lemaître B., Hagan R. M., Krause D. N., Sugden D., Yocca F. D., Vanhoutte P. M.: Melatonin receptors. The IUPHAR Compendium of Receptor Characterization and Classification. IUPHAR Media, London, 1998, 187-193.
64. 125I]-iodomelatonin binding sites in Siberian hamsters by endogenous and exogenous melatonin. Brain Res., 1993, 631, 107-113.
65. Ebisawa T., Karna S., Lerner M. R., Reppert S. M.: Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc. Nat. Acad. Sci. USA, 1994, 91, 6133-6137.
66. Ehret M., Gobaille S., Cash C. D., Mandel P., Maitre M.: Regional distribution of rat brain tryptophan hydroxylase apoenzyme determined by enzyme-linked immunoassay. Neurosci. Lett., 1987, 73, 71-76.
67. Ehret M., Pévet P., Maitre M.: Tryptophan hydroxylase synthesis is induced by 3′,5′-cyclic adenosine monophosphate during circadian rhythm in the rat pineal gland. J. Neurochem., 1991, 57, 1516-1521.
68. Fijii R., Oshima N.: Control of chromophore movements in teleost fishes. Zool. Sci., 1986, 3, 13-47.
69. Florez J. C., Takahashi J. S.: Quantitative 2-dimentional gel-electrophoretic analysis of clock controlling proteins in cultured chick pineal cells - circadian regulation of tryptophan hydroxylase. J. Biol. Rhythms, 1996, 11, 241-257.
70. Foldes A., Maxwell C. A., Rintoul A. J., Scaramuzzi R. J., Baker P.: Effects of melatonin implants on selected hormonal profiles and wool growth in Merino weathers. Anim. Prod. Australia, 1990, 18, 208-211.
71. Folkard A., Arendt J., Aldhous M., Kennett H.: Melatonin stabilizes sleep onset time in a blind man without entrainment of cortisol or temperature rhythms. Neurosci. Lett., 1990, 113, 193-198.
72. Folkard A., Arendt J., Clark M.: Can melatonin improve shift workers' tolerance of the night shift? Some preliminary findings. Chronobiol. Int., 1993, 10, 315-320.
73. Foulkes N. S., Borjigin J., Snyder S. H., Sassone-Corsi P.: Transcriptional control of circadian hormone synthesis via the CREM feedback loop. Proc. Nat. Acad. Sci. USA, 1996, 93, 14140-14145.
74. Foulkes N. S., Borjigin J., Snyder S. H., Sassone-Corsi P.: Rhythmic transcription: the molecular basis of circadian melatonin synthesis. Trends Neurosci., 1997, 10, 487-492.
75. Foulkes N. S., Duval G., Sassone-Corsi P.: Adaptive inducibility of CREM as transcriptional memory of circadian rhythms. Nature, 1996, 381, 83-85.
76. Foulkes N. S., Whitmore D., Sassone-Corsi P.: Rhythmic transcription: the molecular basis of circadian melatonin synthesis. Biol. Cell, 1997, 89, 487-494.
77. Garfinkel D., Laudon M., Nof D., Zisapel N.: Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet, 1995, 346, 551-554.
78. Gastel J. A., Roseboom P. H., Rinaldi P. A., Weller J. L., Klein D. C.: Melatonin production: proteasomal proteolysis in serotonin N-acetyltransferase regulation. Science, 1998, 279, 1358-1360.
79. Gauer F., Masson-Pévet M., Pévet P.: Effect of constant light, pinealectomy and guanosine triphosphate gamma-S on the density of melatonin receptors in the rat suprachiasmatic nucleus: a possible implication of melatonin action. J. Neuroendocrinol., 1993, 4, 456-459.
80. Gauer F., Masson-Pévet M., Pévet P.: Melatonin receptor density is regulated in rat pars tuberalis and suprachiasmatic nuclei by melatonin itself. Brain Res., 1993, 602, 153-156.
81. Gauer F., Masson-Pévet M., Skene D. J., Vivien-Roels B., Pévet P.: Daily rhythms of melatonin binding sites in the rat pars tuberalis and suprachiasmatic nuclei: evidence for a regulation of melatonin receptors by melatonin itself. Neuroendocrinology, 1993, 57, 120-126.
82. Gilad E., Laudon M., Matzkin H., Pick E., Sofer M., Braf Z., Zisapel N.: Functional melatonin receptors in human prostate epithelial cells. Endocrinology, 1996, 137, 1412-1417.
83. Gilad E., Matzkin H., Zisapel N.: Interplay between sex steroids and melatonin in regulation of human benign prostate epithelial cell growth. J. Clin. Endocrinol. Metab., 1997, 82, 2535-2541.
84. Gilad E., Zisapel N.: High-affinity binding of melatonin to hemoglobin. Biochem. Molec. Med., 1995, 56, 115-120.
85. Giusti P., Guselle M., Lipartiti M., Milani D., Zhu W., Vicini S., Manev H.: Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity. Exp. Neurol., 1995, 131, 39-46.
86. 1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology, 1997, 138, 397-404.
87. Goto M., Oshima I., Tomita T., Ebihara S.: Melatonin content of the pineal gland in different mouse strains. J. Pineal Res., 1989, 7, 195-204.
88. Grace M. S., Cahill G. M., Besharse J. C:. Melatonin deacetylation: retinal vertebrate class distribution and Xenopus laevis tissue distribution. Brain Res., 1991, 559, 56-63.
89. Grassi-Zucconi G., Semprevivo M., Mocaer E., Kristensson K., Bentivoglio M.: Melatonin and its new agonist S-20098 restore synchronized sleep fragmented by experimental trypanosome infection in the rat. Brain Res. Bull., 1996, 39, 63-68.
90. Green C. B., Besharse J. C.: Tryptophan hydroxylase expression is regulated by a circadian clock in Xenopus laevis retina. J. Neurochem., 1995, 62, 2420-2428.
91. Guardiola-Lemaître B.: Toxicology of melatonin. J. Biol. Rhythms, 1997, 12, 697-706.
92. Haimov I., Laudon M., Zisapel N., Souroujon M., Nof D., Shlitner A., Herer P., Tzischinsky O., Lavie P.: Impaired 6-sulfatoxymelatonin rhythms in the elderly: coincidence with sleep disorders. Brit. Med. J., 1994, 309, 167.
93. Haimov I., Lavie P.: Potential of melatonin replacement therapy in older patients with sleep disorders. Drug. Aging, 1995, 2, 75-78.
94. Haimov I., Lavie P., Laudon M., Herer P., Vigder C., Zisapel N.: Melatonin replacement therapy of elderly insomniacs. Sleep, 1995, 18, 598-603.
95. Hattori A., Migitaka H., Iigo M., Itoh M., Yamamoto K., Ohtani-Kaneko R., Hara M., Suzuki T., Reiter R. J:. Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem. Mol. Biol. Int., 1995, 35, 627-634.
96. Hazlerigg D. G., Gonzales-Brito A., Lawson W., Hastings M. H., Morgan P. J.: Prolonged exposure to melatonin leads to time-dependent sensitization of adenylate cyclase and down-regulates melatonin receptors in pars tuberalis cells from ovine pituitary. Endocrinology, 1993, 132, 285-292.
97. Honma S., Kanematsu N., Katsuno Y., Honma K.-I:. Light suppression of nocturnal pineal and plasma melatonin in rats depends on wavelength and time of day. Neurosci. Lett., 1992, 147, 201-214.
98. Huether G.: The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia, 1993, 49, 665-670.
99. Hughes R. J., Badia P.: Sleep-promoting and hypothermic effects of daytime melatonin administration in humans. Sleep, 1997, 20, 124-131.
100. Illnerová H., Buresov M., Presl J.: Melatonin rhythm in human milk. J. Clin. Endocrinol. Metab., 1993, 77, 838-841.
101. Jan J. E., Espezel H., Appleton R. E.: The treatment of sleep disorders with melatonin. Develop. Med. Child Neurol., 1994, 36, 97-107.
102. Kennaway D. J.: Development of melatonin production in infants and the impact of prematurity. J. Clin. Endocrinol. Metab., 1992, 75, 367-369.
103. Kivela A.: Serum melatonin during pregnancy. Acta Endocrinol., 1991, 124, 233-237.
104. Klein D. C.: The melatonin rhythm-generating system. In: Light and Biological Rhythms in Man. Ed. Wetterberg L., Pergamon Press, Oxford, 1993, 55-72.
105. Klein D. C., Coon S. L., Roseboom P. H., Weller J. L., Bernard M., Gastel J. A., Zatz M., Iuvone P. M., Rodriguez I. R., Begay V., Falcon J., Cahill G. M., Cassone V. M., Baler R.: The melatonin rhythm-generating enzyme: molecular regulation of serotonin N-acetyltransferase in the pineal gland. Rec. Prog. Horm. Res., 1997, 52, 307-358.
106. Klein D. C., Roseboom P. H, Coon S. L.: New light is shining on the melatonin rhythm enzyme. The first postcloning view. Trends Endocrinol. Metab., 1996, 7, 106-112.
107. Klein D. C., Weller J. L.: Indole metabolism in the pineal gland: a circadian rhythm in N-acetyltransferase. Science, 1970, 169, 1093-1095.
108. 2+, pCREB, and ICER. Naturwissenschaften, 1996, 83, 535-543.
109. Kräuchi K., Wirz-Justice A.: Circadian rhythm of heat production, heart rate and skin and core temperature under unmasking conditions in men. Amer. J. Physiol., 1994, 267, 819-829.
110. Laakso M. L., Hatonen T., Stenberg D., Alila A., Smith S.: One-hour exposure to moderate illuminance (500 lux) shifts the human melatonin rhythm. J. Pineal Res., 1993, 15, 21-26.
111. Laitinen J. T., Castren E., Vakkuri O., Saavedra J. M.: Diurnal rhythm of melatonin binding in the rat suprachiasmatic nucleus. Endocrinology, 1989, 124, 1585-1587.
112. Lane E. A., Moss H. B.: Pharmacokinetics of melatonin in man: first pass hepatic metabolism. J. Clin. Endocrinol. Metab., 1985, 61, 1214-1216.
113. Lapierre O., Dumont M.: Melatonin treatment of a non-24-hour sleep-wake cycle in a blind retarded child. Biol. Psychiat., 1995, 38, 119-122.
114. 125I]iodomelatonin binding sites in visual areas of the turtle brain. Eur. J. Pharmacol., 1996, 297, 181-185.
115. Laudon M., Gilad E., Matzkin H., Braf Z., Zisapel N.: Putative melatonin receptors in benign human prostate tissue. J. Clin. Endocrinol. Metab., 1996, 81, 1336-1342.
116. Lavie P.: Melatonin: role in gating nocturnal rise in sleep propensity. J. Biol. Rhythms, 1997, 12, 657-665.
117. Lerner A. B., Case J. D., Takahashi Y., Lee T. H., Mori W.: Isolation of melatonin, the pineal factor that lightens melanocytes. J. Amer. Chem. Soc., 1958, 80, 2587.
118. Lewy A. J., Ahmed S., Latham-Jackson J. M., Sack R. L.: Melatonin shifts human circadian rhythms according to a phase response curve. Chronobiol. Int., 1992, 9, 380-392.
119. Lewy A. J., Sack R. L.: Exogenous melatonin's phase-shifting effects on the endogenous melatonin profile in sighted humans: a brief review and critique of the literature. J. Biol. Rhythms, 1997, 12, 588-594.
120. Lezoualc'h F., Skutella T., Widmann M., Behl C.: Melatonin prevents oxidative stress-induced cell death in hippocampal cells. NeuroReport, 1996, 7, 2071-2077.
121. Lissoni P., Barni S., Brivio F., Rossini F., Fumagalli L., Ardizzoia A., Tancini G.: A biological study on the efficacy of low dose subcutaneous interleukin-2 plus melatonin in the treatment of cancer-related thrombocytopenia. Oncology, 1995, 52, 360-362.
122. Lissoni P., Barni S., Cattaneo G., Tancini G., Esposti G., Fraschini F.: Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies. Oncology, 1991, 48, 448-450.
123. Lissoni P., Meregalli S., Nosetto L., Barni S., Tancini G., Fossati V., Maestroni G.: Increased survival time in brain glioblastomas by a radioendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone. Oncology, 1996, 53, 43-46.
124. Liu C., Weaver D. R., Jin X., Shearman L. P., Pieschl R. L., Gribkoff V. K., Reppert S. M.: Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron, 1997, 19, 91-102.
125. Lockey S. W., Skene D. J., Arendt J., Tabandeh H., Bird A. C., Defrance R.: Relationship between melatonin rhythms and visual loss in the blind. J. Clin. Endocrinol. Metab., 1997, 82, 3763-3770.
126. Lockey S. W., Skene D. J., Tabandeh H., Bird A. C., Defrance R., Arendt J.: Relationship between napping and melatonin in the blind. J. Biol. Rhythms, 1997, 12, 16-25.
127. Lovenberg W., Jequier E., Sjoerdsma A.: Tryptophan hydroxylation: measurement in pineal gland, brainstem and carcinoid tumor. Science, 1967, 155, 217-219.
128. Maestroni G. J. M., Conti A.: Melatonin and the immune system. In: Melatonin and the Pineal Gland -From Basic Science to Clinical Application. Eds. Touitou Y., Arendt J., Pévet P., Excerpta Medica, Amsterdam, 1993, 295-302.
129. Mahle C. D., Goggins G. D., Agarwal P., Ryan E., Watson A. J.: Melatonin modulates vascular smooth muscle tone. J. Biol. Rhythms, 1997, 12, 690-696.
130. Maronde E., Schomerus C., Stehle J. H., Korf H.-W.: Control of CREB phosphorylation and its role for induction of melatonin synthesis in rat pinealocytes. Biol. Cell, 1997, 89, 505-511.
131. Martinet L., Guardiola-Lemaître B., Mocaer E.: Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent. Pharmacol. Biochem. Behav., 1996, 54, 713-718.
132. Mathe-Allainmat M., Gaudy F., Sicsic S., Dangy-Caye A.-L., Shen S.: Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors. J. Med. Chem., 1996, 39, 3089-3095.
133. McArthur A. J., Gillette M. U., Prosser R. A.: Melatonin directly resets the rat suprachiasmatic circadian clock in vitro. Brain Res., 1991, 565, 158-161.
134. Moore R. Y.: Neuronal control of the pineal gland. Behav. Brain Res., 1996, 73, 125-130.
135. Morgan P. J., Berrett P., Howell E., Helliwell R.: Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem. Int., 1994, 24, 101-146.
136. Murakami N., Nakamura H., Nishi R., Marumoto N., Nasu T.: Comparison of circadian oscillation of melatonin release in pineal cells of house sparrow, pigeon and Japanese quail using cell perfusion systems. Brain Res., 1994, 651, 209-214.
137. Nave R., Herer P., Haimov I., Shlitner A., Lavie P.: Hypnotic and hypothermic effects of melatonin on day-time sleep in humans: lack of antagonism by flumazenil. Neurosci. Lett., 1996, 214, 123-126.
138. Nelson C. S., Marino J. L., Allen C. N.: Melatonin receptors activate heteromeric G-protein coupled Kir3 channels. NeuroReport, 1996, 7, 717-720.
139. Nickelsen T., Lang A., Bergau L.: The effect of 6-, 9-, and 11-hour time shifts on circadian rhythms: adaptation of sleep parameters and hormonal patterns following the intake of melatonin or placebo. Adv. Pineal Res., 1991, 5, 303-306.
140. Niki T., Hamada T., Ohtomi M., Sakamoto K., Suzuki S., Kako K., Hosoya Y., Horikawa K., Ishida N.: The localization of the site of arylamine N-acetyltransferase circadian expression in the photoreceptor cells of mammalian retina. Biochem. Biophys. Res. Commun., 1998, 248, 115-120.
141. Nowak J. Z., Szymańska B., Zawilska J. B., Białek B.: Hydroxyindole-O-methyltransferase (HIOMT) activity in some brain and ocular structures of rabbit and hen. J. Pineal Res., 1993, 15, 35-42.
142. Nowak J. Z., Zawilska J. B.: Melatonin and its physiological and therapeutic properties. Pharm. World Sci., 1998, 20, 18-27.
143. Nowak J. Z., Zawilska J. B., Rosiak J., Bednarska K.: Melatonin generating system of the vertebrate retina: characteristics and regulation by visible and UV light. In: Pineal Gland Update. Eds. Moller M., Pévet P., Puig-Domingo M., Webb S., Westbury, PDJ Publications Ltd, 1997, 133-141.
144. Nowak J. Z., Żurawska E., Zawilska J.: Melatonin and its generating system in vertebrate retina: circadian rhythm, effect of environmental lighting, and interaction with dopamine. Neurochem. Int., 1989, 14, 397-406.
145. Oldani A., Ferini-Strambi L., Zucconi M., Stankov B., Fraschini F., Smirne S.: Melatonin and delayed sleep phase syndrome: ambulatory polygraphic evaluation. NeuroReport, 1994, 6, 132-134.
146. Pablos M., Reiter R. J., Ortiz G. G., Guerrero J. M., Agapito M. T., Chuang J. I., Sewerynek E.: Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochem. Int., 1998, 32, 69-75.
147. Palm L., Blennow G., Wetterberg L.: Correction of non-24-hour sleep/wake cycle by melatonin in a blind retarded boy. Ann. Neurol., 1991, 29, 336-339.
148. Pierrefiche G., Laborit H.: Oxygen free radicals, melatonin, and aging. Exp. Gerontol., 1995, 30, 213-227.
149. Podolin P. L., Pangerl A., Brainard G. C.: The suppression of nocturnal pineal melatonin in the Syrian hamster: dose-response curves at 500 and 360 nm. Endocrinology, 1987, 121, 266-270.
150. Poeggeler B., Balzer I., Harderland R., Lerchl A.: Pineal hormone melatonin oscillates also in the dinoflagellate Gonyaulax polyedra. Naturwissenschaften, 1991, 78, 268-269.
151. Popova J. S., Dubocovich M. L.: Melatonin receptor-mediated stimulation of phosphoinositide breakdown in chick brain slices. J. Neurochem., 1995, 64, 130-138.
152. Reiter R. J.: The melatonin message: duration versus coincidence hypotheses. Life Sci., 1987, 46, 2119-2131.
153. Reiter R. J.: Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrinol. Rev., 1991, 12, 151-180.
154. Reiter R. J.: The mammalian pineal gland as an end organ of the visual system. In: Light and Biological Rhythms in Man. Ed. Wetterberg L., Pergamon Press, Oxford, 1993, 145-160.
155. Reiter R. J.: The melatonin rhythm: both a clock and a calendar. Experientia, 1993, 49, 654-664.
156. Reiter R. J.: Pineal function during aging: attenuation of the melatonin rhythm and its neurological consequences. Acta Neurobiol. Exp., 1994, 54 Suppl., 31-39.
157. Reiter R. J., Hurlbut E. C., Brainard G. C., Steinlechner S., Richardson B. A.: Influence of light irradiance on hydroxyindole-O-methyltransferase activity, serotonin N-acetyltransferase activity, and radioimmunoassayable melatonin levels in the pineal gland of the diurnally active Richardson's ground squirrel. Brain Res., 1983, 288, 151-157.
158. Reiter R. J., Melchiori D., Sewerynek E., Paeggeler B., Barlow-Walden L., Chuang J., Ortiz G. G., Acuna-Castroviejo D.: A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res., 1995, 18, 1-11.
159. Reiter R., Tang L., Garaic J.J., Munoz-Hoyos A.: Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci., 1997, 60, 2255-2271.
160. 1b melatonin receptor. Proc. Nat. Acad. Sci. USA, 1995, 92, 8734-8738.
161. Reppert S. M., Weaver D. R.: Melatonin madness. Cell, 1995, 83, 1059-1062.
162. Reppert S. M., Weaver D. R., Cassone V. M., Godson C., Kolakowski L. F.: Melatonin receptors are for birds: molecular analysis of two receptor subtypes differentially expressed in chick brain. Neuron, 1995, 15, 1003-1015.
163. Reppert S. M., Weaver D. R., Ebisawa T.: Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron, 1995, 13, 1177-1185.
164. Reppert S. M., Weaver D. R., Godson C.: Melatonin receptors step into light: cloning and classification of subtypes. Trends Pharmacol. Sci., 1996, 17, 100-102.
165. Rivkess S. A., Cassone V. M., Weaver D. R., Reppert S. M.: Melatonin receptors in chick brain: characterization and localization. Endocrinology, 1989, 125, 363-368.
166. Roberston L. M., Takahashi J. S.: Circadian clock in cell culture. I. Oscillation of melatonin release from dissociated chick pineal cells. J. Neurosci., 1988, 8, 12-21.
167. Robertson L. M., Takahashi J. S.: Circadian clock in cell culture. II. In vitro entrainment of melatonin oscillation from dissociated chick pineal cells. J. Neurosci., 1988, 8, 22-30.
168. 1a melatonin receptor. Endocrinology, 1996, 137, 3469-3477.
169. Rollag M. D.: Response of amphibian melanophores to melatonin. Pineal Res. Rev., 1988, 6, 67-93.
170. Roseboom P. H., Coon S. L., Baler R., McCune S. K., Weller J. L., Klein D. C.: Melatonin synthesis: analysis of the >150-fold increase in serotonin N-acetyltransferase mRNA in the rat pineal gland. Endocrinology, 1996, 137, 3033-3044.
171. Roseboom P. H., Klein D. C.: Norepinephrine stimulation of pineal cyclic AMP response element-binding protein phosphorylation: primary role of a β-adrenergic receptor/cyclic AMP mechanism. Mol. Pharmacol., 1995, 47, 439-449.
172. Sack R. L., Lewy A. J.: Melatonin as a chronobiotic: treatment of circadian desynchrony in night workers and in the blind. J. Biol. Rhythms, 1997, 12, 595-603.
173. Sack R. L., Lewy A. J., Blood M. L., Stevenson J., Keith L. D:. Melatonin administration to blind people: phase advances and entrainment. J. Biol. Rhythms, 1991, 6, 249-261.
174. Shanahan T. L., Neri D., Czeisler C. A.: The melatonin rhythm observed during three months of rotating shift work. In: Stress Research Reports. Eds. Ǎkerstedt T., Kecklund G., Karolinska Institute, Stockholm, 1994, 119.
175. Shanahan T. L., Zeitzer J. M., Czeisler C. A.: Ressetting the melatonin rhythm with light in humans. J. Biol. Rhythms, 1997, 12, 556-567.
176. Shibata S., Cassone V. M., Moore R. Y.: Effects of melatonin on neuronal activity in the rat suprachiasmatic nucleus in vitro. Neurosci. Lett., 1989, 97, 140-144.
177. Shibuya H., Toru M., Watanabe S.: A circadian rhythm of tryptophan hydroxylase in rat pineals. Brain Res., 1978, 138, 364-368.
178. Shochat T., Luboshitsky R., Lavie P.: Nocturnal melatonin onset is phase locked to the primary sleep gate. Amer. J. Physiol., 1997, 273, R364-R370.
179. Skene D. J., Deacon S., Arendt J.: Use of melatonin in circadian rhythm disorders and following phase shifts. Acta Neurobiol. Exp., 1996, 56, 359-362.
180. Staples L. D., McPhee S., Reeve J., Williams A. H.: Practical applications for controlled release melatonin implants in sheep. In: Advances in Pineal Research, vol. 6. Eds. Reiter R. J., Foldes A., John Libbey, London, 1991, 199-208.
181. Starkey S. J., Walker M. P., Beresford J. M., Hagan R. M.: Modulation of the rat suprachiasmatic circadian clock by melatonin in vitro. NeuroReport, 1995, 6, 1947-1951.
182. Stehle J. H., Foulkes N. S., Molina C. A., Simonneaux V., Pévet P., Sassone-Corsi P.: Adrenergic signals direct rhythmic expression of transcriptional repressor CREM in the pineal gland. Nature, 1993, 365, 314-320.
183. Stehle J. H., Foulkes N. S., Pévet P., Sassone-Corsi P.: Developmental modulation of pineal gland function: synchronized CREM inducibility and adrenergic stimulation. Mol. Endocrinol., 1995, 9, 706-716.
184. Stehle J. H., Vanecek J., Vollrath L.: Effects of melatonin on spontaneous electrical activity of neurons in rat suprachiasmatic nuclei: an in vitro iontophoretic study. J. Neural Transm.-Gen. Sect., 1989, 78, 173-177.
185. Steinhilber D., Brungs M., Werz O., Wiesenber I., Danielsson C., Kahlen J.-P., Nayeri S., Schrader M., Carlberg C.: The nuclear receptor for melatonin represses 5-lipooxygenase gene expression in human B lymphocytes. J. Biol. Chem., 1995, 270, 7037-7040.
186. Sugden D.: N-Acyl-3-amino-5-methoxychromans: a new series of non-indolic melatonin analogues. Eur. J. Pharmacol., 1994, 254, 271-275.
187. Sugden D., Cena V., Klein D. C.: Hydroxyindole-O-methyltransferase. Methods Enzymol., 1987, 142, 590-595.
188. Sugden D., Klein D. C.: Adrenergic stimulation of rat pineal hydroxyindole-O-methyltransferase. Brain Res., 1983, 265, 348-351.
189. Sun Y.-H., Yaga K., Reiter R. J., Garza M., Manchaster L. C., Tan D.-X., Poeggeler B.: Reduction in pineal N-aceryltransferase activity and pineal and serum melatonin levels in rats after their exposure to red light at night. Neurosci. Lett., 1993, 149, 56-58.
190. Takahashi J. S., DeCoursey P., Bauman L., Menaker M.: Spectral sensitivity of a novel photoreceptive system mediating entrainment of mammalian circadian rhythms. Nature, 1984, 308, 186-188.
191. Thomas K. B., Iuvone P. M.: Circadian rhythm of tryptophan hydroxylase activity in chicken retina. Cell. Mol. Neurobiol., 1991, 11, 511-517.
192. Tosini G., Menaker M.: Circadian rhythms in cultured mammalian retina. Science, 1996, 272, 419-421.
193. Turek F. W.: Melatonin hype hard to swallow. Nature, 1996, 379, 295-296.
194. Tzischinsky O., Dagan Y., Lavie P.: The effects of melatonin on the timing of sleep in patients with delayed sleep phase syndrome. In: Melatonin and the Pineal Gland - From Basic Science to Clinical Applications. Eds. Touitou Y., Arendt J., Pévet P., Excerpta Medica, Amsterdam, 1993, 351-354.
195. Tzischinsky O., Pal I., Epstein R., Dagan Y., Lavie P.: The importance of timing in melatonin administration in a blind man. J. Pineal Res., 1992, 12, 105-108.
196. Underwood H., Barret R. K., Siopes T.: The quail's eye: a biological clock. J. Biol. Rhythms, 1990, 5, 257-265.
197. Vanecek J., Vollrath L.: Melatonin inhibits cyclic AMP and cyclic GMP accumulation in the rat pituitary. Brain Res., 1989, 505, 157-159.
198. Vanecek J., Vollrath L.: Melatonin modulates diacylglycerol and arachidonic acid metabolism in the anterior pituitary of immature rats. Neurosci. Lett., 1990, 110, 199-203.
199. Viswanathan M., Laitinen J. T., Saavedra J. M.: Expression of melatonin receptors in arteries involved in thermoregulation. Proc. Nat. Acad. Sci. USA, 1990, 87, 6200-6203.
200. Vivien-Roels B., Pévet P.: Melatonin: presence and formation in invertebrates. Experientia, 1993, 49, 642-647.
201. Waldhauser F., Dietzel M.: Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann. NY Acad. Sci. 1985, 453, 205-214.
202. Waldhauser F., Saletu B., Trinchard-Lugan I.: Sleep laboratory investigations on hypnotic properties of melatonin. Psychopharmacology, 1990, 100, 222-226.
203. Waldhauser F., Waldhauser M., Leberman H. R., Deng M. H., Lynch H. J., Wurtman R. J.: Bioavailability of oral melatonin in humans. Neuroendocrinology, 1984, 39, 307-313.
204. Weaver D. R.: Reproductive safety of melatonin: a "wonder drug" to wonder about. J. Biol. Rhythms, 1997, 12, 682-690.
205. Wiechmann A. F., Wirsig-Wiechmann C. R.: Distribution of melatonin receptors in the brain of the frog Rana pipiens as revealed by in vitro autoradiography. Neuroscience, 1993, 52, 469-480.
206. Wiechmann A. F., Wirsig-Wiechmann C. R.: Melatonin distribution in the brain and retina of a lizard, Anolis carolinensis. Brain Behav. Evol., 1994, 43, 26-33.
207. Wirz-Justice A., Armstrong S. M.: Melatonin: nature's soporific? J. Sleep Res., 1996, 5, 137-141.
208. Yoshimura T., Nagabukuro A., Matsuda Y., Suzuki T., Kuroiwa A., Iigo M., Namikawa T., Ebihara S.: Chromosomal mapping of the gene encoding serotonin N-acetyltransferase to rat chromosome 10q32.3 and mouse chromosome 11E2. Cytogenet. Cell Genet., 1997, 79, 172-175.
209. Zawilska J. B.: Clonidine in vivo mimics the acute suppressive but not the phase-shifting effects of light on the circadian rhythm of serotonin N-acetyltransferase activity in chick pineal gland. J. Pineal Res., 1994, 17, 63-68.
210. 4-like dopamine receptor suppresses serotonin N-acetyltransferase activity but does not phase-shift the circadian oscillator in chick retina. Neurosci. Lett., 1994, 179, 107-110.
211. 4-like dopamine receptor. J. Neural Transm.-Gen. Sect., 1994, 97, 107-117.
212. 2-dopamine receptor-mediated regulation of serotonin N-acetyltransferase activity. Neurosci. Lett., 1992, 135, 71-74.
213. Zawilska J. B., Jarmak A., Woldan-Tambor A., Nowak J. Z.: Light-induced suppression of nocturnal serotonin N-acetyltransferase in chick pineal gland and retina: a wavelength comparison. J. Pineal Res., 1995, 19, 87-92.
214. Zawilska J. B., Nowak J. Z.: Regulatory mechanisms in melatonin biosynthesis in retina. Neurochem. Int., 1992, 20, 23-36.
215. 4 dopamine receptor mediate the inhibitory effect of light on melatonin biosynthesis in chick retina? Neurosci. Lett., 1994, 166, 203-206.
216. Zawilska J. B., Nowak J. Z.: Melatonin receptors (Polish). In: Receptors: Characteristics, Structure, Function. Eds. Nowak J. Z., Zawilska J. B., PWN, Warszawa, 1997, 190-210.
217. Zawilska J. B., Rosiak J. Z., Nowak J. Z.: Effects of near-ultraviolet light on the nocturnal serotonin N-acetyltransferase activity of rat pineal gland. Neurosci. Lett., 1998, 243, 49-52.
218. Zawilska J. B., Rosiak J., Nowak J. Z.: The effects of near-ultraviolet light on serotonin N-acetyltransferase activity in chick pineal gland. J. Pineal Res., 1998, in press.
219. Zawilska J. B., Rosiak J., Trzepizur K., Nowak J. Z.: Catecholamines mediate the suppressive effect of UV-A irradiation on melatonin biosynthesis in vertebrate retina and pineal gland. Acta Neurobiol. Exp., 1997, 57 Suppl., 6.
220. Zawilska J. B., Wawrocka M.: Chick retina and pineal gland differentially respond to constant light and darkness: in vivo studies on serotonin N-acetyltransferase (NAT) activity and melatonin content. Neurosci. Lett., 1993, 153, 21-24.
221. Zhdanova I. V., Wurtman R. J.: Efficiacy of melatonin as a sleep-promoting agent. J. Biol. Rhythms, 1997, 12, 644-650.
222. Zhdanova I. V., Wurtman R. J., Lynch H. J., Ives J. R., Dollins A. B., Morabito C., Metheson J. K., Schomer D. L.: Sleep-inducing effect of low doses of melatonin ingested in the evening. Clin. Pharmacol., 1995, 57, 552-558.